ADAR1 Capital Management »

Voyager Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Voyager Therapeutics (VYGR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Voyager Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Voyager Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Voyager Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $852k 92k 9.31
2023-12-31 $1.6M 186k 8.44

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Voyager Therapeutics

BlackRock
BlackRock
Armistice Capital
EcoR1 Capital
Vanguard Group
Farallon Capital Management
State Street Corporation
Dimensional Fund Advisors
Geode Capital Management
Erste Asset Management GmbH
Dr. Jeffrey R. Jay, M.D.
T. Rowe Price Associates
Federated Investors
Bank of America Corporation
Morgan Stanley

View all funds holding Voyager Therapeutics